Загрузка...
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
The aim of this study was to investigate the potential of progesterone receptor (PgR) as a biomarker for differentiating estrogen receptor (ER)-positive patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy (NCT) with different prognoses. A total of 327 consecutiv...
Главные авторы: | , , , |
---|---|
Формат: | Online Статья Текст |
Язык: | English |
Опубликовано: |
Impact Journals LLC
2015
|
Предметы: | |
Online-ссылка: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627243/ https://www.ncbi.nlm.nih.gov/pubmed/26053183 |